Browsing Tag
Dana-Farber Cancer Institute
4 posts
AACR Annual Meeting 2026: what cancer researchers and pharma professionals need to know before San Diego
AACR Annual Meeting 2026 runs April 17-22 at San Diego Convention Center. Over 7,400 abstracts, six plenaries, AI, CAR T, ADCs and RAS inhibitor data.
Sun Pharmaceutical (NSE: SUNPHARMA) launches UNLOXCYT in U.S. for aCSCC
Sun Pharma's UNLOXCYT is now available in the U.S. for advanced CSCC. Find out how this checkpoint inhibitor could reshape skin cancer treatment today.
Former MADD CEO Debbie Weir joins Cancer Vaccine Coalition to accelerate therapeutic cancer vaccine movement
Debbie Weir, former MADD CEO, joins Cancer Vaccine Coalition to accelerate clinical trials and advocacy for therapeutic cancer vaccines in the U.S.
Pan-Mass Challenge 2025 unites 6,500+ riders to target record $76M for Dana-Farber cancer research
More than 6,500 riders join the 2025 Pan-Mass Challenge to raise $76M for Dana-Farber Cancer Institute, building on $1B in lifetime cancer research funding.